Elocon and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elocon (mometasone furoate) and Remeron (mirtazapine). Common drug interactions include urinary tract infection among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Elocon and Remeron. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Elocon?

Elocon has active ingredients of mometasone furoate. It is often used in eczema. eHealthMe is studying from 2,019 Elocon users. Check the latest studies of Elocon.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.



On Jul, 14, 2026

17 people who take Elocon and Remeron together, and have interactions are studied.

Elocon and Remeron drug interactions.

What are the common drug interactions of Elocon and Remeron, by gender? *:

female:

  1. Urinary tract infection
  2. Abasia (inability to walk)
  3. Abdominal distension
  4. Abdominal pain
  5. Abdominal pain upper
  6. Anaemia of chronic disease
  7. Asthenia (weakness)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Back pain

male:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cardiac failure congestive
  3. Anaemia (lack of blood)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Apathy
  6. Apnoea (suspension of external breathing)
  7. Arthralgia (joint pain)
  8. Asthenia (weakness)
  9. Atelectasis (partial or complete collapse of the lung)
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

What are the common drug interactions of Elocon and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Cough
  3. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  4. Parkinson's disease
  5. Sleep disorder

50-59:

  1. Depressed mood
  2. Diabetes mellitus non-insulin-dependent
  3. Diabetic cardiomyopathy (disorder of the heart muscle in people with diabetes)
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fatigue (feeling of tiredness)
  7. Foreign body sensation in eyes (feeling of something in eye)
  8. Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
  9. Hypoglycaemia (deficiency of glucose in the bloodstream)
  10. Laryngitis (inflammation of the larynx)

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Decreased appetite
  4. Dizziness
  5. Epistaxis (bleed from the nose)
  6. Fatigue (feeling of tiredness)
  7. Headache (pain in head)
  8. Hypercholesterolaemia (high levels of cholesterol in the blood)
  9. Hypokalaemia (low potassium)
  10. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 17.65%
  2. Cough: 3 people, 17.65%
  3. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 17.65%
  4. Pain: 3 people, 17.65%
  5. Muscle Spasms (muscle contraction): 3 people, 17.65%
  6. Migraine (headache): 3 people, 17.65%
  7. Urge Incontinence (urinary incontinence): 2 people, 11.76%
  8. Back Pain: 2 people, 11.76%
  9. Diabetes Mellitus Inadequate Control: 2 people, 11.76%
  10. Dizziness: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Elocon and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elocon and Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elocon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elocon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate and mirtazapine (the active ingredients of Elocon and Remeron, respectively), and Elocon and Remeron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: